Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 2
2003 1
2004 2
2005 2
2006 1
2007 3
2008 3
2009 2
2010 4
2011 6
2012 2
2013 5
2014 7
2015 8
2016 8
2017 11
2018 9
2019 15
2020 12
2021 16
2022 8
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
[Hypothyroidism].
Köhler VF, Spitzweg C. Köhler VF, et al. Among authors: spitzweg c. MMW Fortschr Med. 2021 Oct;163(17):44-49. doi: 10.1007/s15006-021-0264-2. MMW Fortschr Med. 2021. PMID: 34595647 Review. German. No abstract available.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ; DECISION investigators. Brose MS, et al. Lancet. 2014 Jul 26;384(9940):319-28. doi: 10.1016/S0140-6736(14)60421-9. Epub 2014 Apr 24. Lancet. 2014. PMID: 24768112 Free PMC article. Clinical Trial.
[Thyroid nodules: What now?].
Ladurner R, Hallfeldt K, Angele M, Werner J, Reincke M, Spitzweg C, Lottspeich C. Ladurner R, et al. Among authors: spitzweg c. MMW Fortschr Med. 2019 Apr;161(7):38-43. doi: 10.1007/s15006-019-0406-y. MMW Fortschr Med. 2019. PMID: 30989520 Review. German. No abstract available.
Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA, Nelson PJ, Spitzweg C. Schmohl KA, et al. Among authors: spitzweg c. Endocr Relat Cancer. 2019 Jun 1;26(6):R287-R304. doi: 10.1530/ERC-19-0058. Endocr Relat Cancer. 2019. PMID: 31063970 Review.
[Advanced radioiodine-refractory differentiated thyroid cancer].
Spitzweg C, Auernhammer CJ, Geisler J, Böck S, Heinemann V, Bartenstein P, Göke B. Spitzweg C, et al. Dtsch Med Wochenschr. 2015 Feb;140(3):168-71. doi: 10.1055/s-0041-100196. Epub 2015 Feb 6. Dtsch Med Wochenschr. 2015. PMID: 25658401 Review. German. No abstract available.
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer.
Koehler VF, Achterfeld J, Sandner N, Koch C, Wiegmann JP, Ivanyi P, Käsmann L, Pusch R, Wolf D, Chirica M, Knösel T, Demes MC, Kumbrink J, Vogl TJ, Meyer G, Spitzweg C, Bojunga J, Kroiss M. Koehler VF, et al. Among authors: spitzweg c. J Cancer Res Clin Oncol. 2023 Nov;149(15):14035-14043. doi: 10.1007/s00432-023-05134-x. Epub 2023 Aug 7. J Cancer Res Clin Oncol. 2023. PMID: 37548775 Free PMC article.
New drugs for medullary thyroid cancer: new promises?
Spitzweg C, Morris JC, Bible KC. Spitzweg C, et al. Endocr Relat Cancer. 2016 Jun;23(6):R287-97. doi: 10.1530/ERC-16-0104. Epub 2016 May 16. Endocr Relat Cancer. 2016. PMID: 27185870 Review.
Leveraging the immune system to treat advanced thyroid cancers.
French JD, Bible K, Spitzweg C, Haugen BR, Ryder M. French JD, et al. Among authors: spitzweg c. Lancet Diabetes Endocrinol. 2017 Jun;5(6):469-481. doi: 10.1016/S2213-8587(16)30277-7. Epub 2016 Oct 20. Lancet Diabetes Endocrinol. 2017. PMID: 27773653 Review.
122 results